Bioceutical company Medolife Rx recently entered an agreement with international product distributors Xoles Del Pacifico that will allow the Burbank-based company to distribute its products in Mexico.  

The partnership will enable Medolife, a majority-owned subsidiary of Quanta Inc. also in Burbank, to sell its Immunapen product line and its CBD and non-CBD pain relief/muscle creams. Immunapen is an over-the-counter homeopathic drug designed to enhance the immune system and promote sleep, reduce anxiety and improve energy and focus.  

Medolife will also use its patented polarization technology to enhance pre-existing over-the-counter products such as male enhancement products and vitamins. Medolife and Xoles will collaborate on the development of other topical pain management products.  


Subscribe to get the full story.

Are you a subscriber? Sign In